CV Death or HF Rehospitalization Following Aliskiren Treatment
Reproduced from Gheorghiade M et al. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: The ASTRONAUT randomized trial. JAMA 2013;309(11):1125–1135. With permission from the American Medical Association.
Effects of Sildenfil on Exercise Capacity and Clinical Outcome
Reproduced from Redfield MM et al. Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial: Effect of PDE-5 on Exercise and Clinical Status in HFPEF. JAMA 2013;309(12):1268. With permission from the American Medical Association.